Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Linfolysin: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Linfolysin - General Information

A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin&

 

Pharmacology of Linfolysin

Linfolysin is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Alkylating agents are cell cycle-nonspecific. Alkylating agents work by three different mechanisms all of which achieve the same end result - disruption of DNA function and cell death.

 

Linfolysin for patients

 

Linfolysin Interactions

There are no known drug/drug interactions with chlorambucil.

 

Linfolysin Contraindications

Chlorambucil should not be used in patients whose disease has demonstrated a prior resistance to the agent. Patients who have demonstrated hypersensitivity to chlorambucil should not be given the drug.There may be cross-hypersensitivity (skin rash) between chlorambucil and other alkylating agents.

 

Additional information about Linfolysin

Linfolysin Indication: For treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and Hodgkin's disease Mechanism Of Action: Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations. Drug Interactions: Not Available Food Interactions: Take on an empty stomach.Drink liberally.Food reduces bioavailability. Generic Name: Chlorambucil Synonyms: Chloraminophen; Chloraminophene; Phenylbutyric Acid Nitrogen Mustard; Chlorobutine; Chlorobutin; Chloroambucil; Chlorbutine; Chlorbutin; Chlocambucil Drug Category: Antineoplastic Agents Drug Type: Small Molecule; Approved Other Brand Names containing Chlorambucil: Ambochlorin; Amboclorin; Ecloril; Elcoril; Leukeran; Leukeran Tablets; Leukersan; Leukoran; Linfolizin; Linfolysin; Pepstatin; Absorption: Not Available Toxicity (Overdose): Not Available Protein Binding: 99% Biotransformation: Not Available Half Life: 1.5 hours Dosage Forms of Linfolysin: Tablet Oral Chemical IUPAC Name: 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid Chemical Formula: C14H19Cl2NO2 Chlorambucil on Wikipedia: https://en.wikipedia.org/wiki/Chlorambucil Organisms Affected: Humans and other mammals